nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.0271	0.0429	CcSEcCtD
Treprostinil—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.0233	0.0368	CcSEcCtD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—RARA—amyotrophic lateral sclerosis	0.0212	0.0801	CbGpPWpGaD
Treprostinil—PTGIR—Endothelin Pathways—ECE1—amyotrophic lateral sclerosis	0.0196	0.074	CbGpPWpGaD
Treprostinil—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.0189	0.03	CcSEcCtD
Treprostinil—Gout—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0292	CcSEcCtD
Treprostinil—PTGIR—hindbrain—amyotrophic lateral sclerosis	0.018	0.174	CbGeAlD
Treprostinil—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.0174	0.0276	CcSEcCtD
Treprostinil—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.0172	0.0273	CcSEcCtD
Treprostinil—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.0171	0.0646	CbGpPWpGaD
Treprostinil—Melaena—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0266	CcSEcCtD
Treprostinil—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.0158	0.0251	CcSEcCtD
Treprostinil—PPARD—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.0157	0.0591	CbGpPWpGaD
Treprostinil—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.0156	0.0247	CcSEcCtD
Treprostinil—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.0149	0.0237	CcSEcCtD
Treprostinil—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.0138	0.0218	CcSEcCtD
Treprostinil—Cardiac failure—Riluzole—amyotrophic lateral sclerosis	0.0128	0.0203	CcSEcCtD
Treprostinil—PPARD—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.0124	0.0467	CbGpPWpGaD
Treprostinil—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.0116	0.0184	CcSEcCtD
Treprostinil—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.0114	0.018	CcSEcCtD
Treprostinil—Influenza—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0171	CcSEcCtD
Treprostinil—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0165	CcSEcCtD
Treprostinil—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0164	CcSEcCtD
Treprostinil—PTGIR—brainstem—amyotrophic lateral sclerosis	0.0103	0.0997	CbGeAlD
Treprostinil—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00969	0.0153	CcSEcCtD
Treprostinil—Depression—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0152	CcSEcCtD
Treprostinil—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00937	0.0148	CcSEcCtD
Treprostinil—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00919	0.0145	CcSEcCtD
Treprostinil—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00909	0.0144	CcSEcCtD
Treprostinil—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00904	0.0143	CcSEcCtD
Treprostinil—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00881	0.0139	CcSEcCtD
Treprostinil—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.0087	0.0138	CcSEcCtD
Treprostinil—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00867	0.0137	CcSEcCtD
Treprostinil—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00865	0.0137	CcSEcCtD
Treprostinil—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00859	0.0136	CcSEcCtD
Treprostinil—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00852	0.0135	CcSEcCtD
Treprostinil—P2RY12—nervous system—amyotrophic lateral sclerosis	0.00848	0.0819	CbGeAlD
Treprostinil—P2RY12—central nervous system—amyotrophic lateral sclerosis	0.00817	0.0788	CbGeAlD
Treprostinil—Tension—Riluzole—amyotrophic lateral sclerosis	0.00739	0.0117	CcSEcCtD
Treprostinil—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00731	0.0116	CcSEcCtD
Treprostinil—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00728	0.0115	CcSEcCtD
Treprostinil—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00724	0.0115	CcSEcCtD
Treprostinil—P2RY12—Signal amplification—PLA2G4A—amyotrophic lateral sclerosis	0.00712	0.0269	CbGpPWpGaD
Treprostinil—PPARD—nervous system—amyotrophic lateral sclerosis	0.00705	0.068	CbGeAlD
Treprostinil—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00699	0.0111	CcSEcCtD
Treprostinil—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00696	0.011	CcSEcCtD
Treprostinil—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00688	0.0109	CcSEcCtD
Treprostinil—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00679	0.0108	CcSEcCtD
Treprostinil—PPARD—central nervous system—amyotrophic lateral sclerosis	0.00678	0.0655	CbGeAlD
Treprostinil—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00675	0.0107	CcSEcCtD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.00672	0.0254	CbGpPWpGaD
Treprostinil—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00666	0.0105	CcSEcCtD
Treprostinil—PPARD—cerebellum—amyotrophic lateral sclerosis	0.00663	0.064	CbGeAlD
Treprostinil—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00662	0.0105	CcSEcCtD
Treprostinil—Cough—Riluzole—amyotrophic lateral sclerosis	0.00657	0.0104	CcSEcCtD
Treprostinil—P2RY12—brain—amyotrophic lateral sclerosis	0.00648	0.0626	CbGeAlD
Treprostinil—PTGIR—spinal cord—amyotrophic lateral sclerosis	0.00642	0.062	CbGeAlD
Treprostinil—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0101	CcSEcCtD
Treprostinil—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0101	CcSEcCtD
Treprostinil—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00641	0.0101	CcSEcCtD
Treprostinil—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00639	0.0101	CcSEcCtD
Treprostinil—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00633	0.01	CcSEcCtD
Treprostinil—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00615	0.00973	CcSEcCtD
Treprostinil—Infection—Riluzole—amyotrophic lateral sclerosis	0.00611	0.00967	CcSEcCtD
Treprostinil—Shock—Riluzole—amyotrophic lateral sclerosis	0.00605	0.00957	CcSEcCtD
Treprostinil—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00602	0.00953	CcSEcCtD
Treprostinil—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.006	0.0095	CcSEcCtD
Treprostinil—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00586	0.00927	CcSEcCtD
Treprostinil—PPARD—Adipogenesis—RARA—amyotrophic lateral sclerosis	0.00585	0.0221	CbGpPWpGaD
Treprostinil—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00574	0.00909	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0056	0.00886	CcSEcCtD
Treprostinil—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00556	0.0088	CcSEcCtD
Treprostinil—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00552	0.00874	CcSEcCtD
Treprostinil—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00548	0.00867	CcSEcCtD
Treprostinil—PTGIR—nervous system—amyotrophic lateral sclerosis	0.00541	0.0522	CbGeAlD
Treprostinil—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00541	0.00856	CcSEcCtD
Treprostinil—PPARD—brain—amyotrophic lateral sclerosis	0.00539	0.052	CbGeAlD
Treprostinil—PPARD—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	0.00537	0.0203	CbGpPWpGaD
Treprostinil—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00534	0.00846	CcSEcCtD
Treprostinil—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.0053	0.00839	CcSEcCtD
Treprostinil—Pain—Riluzole—amyotrophic lateral sclerosis	0.00526	0.00832	CcSEcCtD
Treprostinil—PTGIR—central nervous system—amyotrophic lateral sclerosis	0.00521	0.0503	CbGeAlD
Treprostinil—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00517	0.0196	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.00513	0.0194	CbGpPWpGaD
Treprostinil—PTGIR—cerebellum—amyotrophic lateral sclerosis	0.00509	0.0492	CbGeAlD
Treprostinil—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00506	0.00802	CcSEcCtD
Treprostinil—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00503	0.00796	CcSEcCtD
Treprostinil—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00769	CcSEcCtD
Treprostinil—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00486	0.00769	CcSEcCtD
Treprostinil—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00441	0.00698	CcSEcCtD
Treprostinil—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00435	0.00688	CcSEcCtD
Treprostinil—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00421	0.00666	CcSEcCtD
Treprostinil—PTGIR—brain—amyotrophic lateral sclerosis	0.00414	0.0399	CbGeAlD
Treprostinil—PPARD—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	0.00407	0.0154	CbGpPWpGaD
Treprostinil—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00643	CcSEcCtD
Treprostinil—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00391	0.00619	CcSEcCtD
Treprostinil—Rash—Riluzole—amyotrophic lateral sclerosis	0.00388	0.00613	CcSEcCtD
Treprostinil—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00387	0.00613	CcSEcCtD
Treprostinil—Headache—Riluzole—amyotrophic lateral sclerosis	0.00385	0.0061	CcSEcCtD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.00379	0.0143	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.00379	0.0143	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00376	0.0142	CbGpPWpGaD
Treprostinil—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00578	CcSEcCtD
Treprostinil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00344	0.013	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00342	0.0129	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.00341	0.0129	CbGpPWpGaD
Treprostinil—PTGIR—Platelet homeostasis—PLA2G4A—amyotrophic lateral sclerosis	0.00313	0.0118	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00313	0.0118	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.00291	0.011	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.0029	0.0109	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00285	0.0108	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00282	0.0106	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00273	0.0103	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.00259	0.00979	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ZNF470—amyotrophic lateral sclerosis	0.00258	0.00976	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00227	0.00856	CbGpPWpGaD
Treprostinil—PPARD—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.00227	0.00856	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—SMN1—amyotrophic lateral sclerosis	0.0022	0.0083	CbGpPWpGaD
Treprostinil—PPARD—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	0.00214	0.00807	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00209	0.00788	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—ZNF746—amyotrophic lateral sclerosis	0.00196	0.0074	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.00195	0.00738	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00187	0.00708	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00182	0.00686	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.0018	0.00679	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00176	0.00664	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00173	0.00652	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.00167	0.00631	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.00165	0.00623	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.00162	0.00611	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00159	0.006	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.00155	0.00587	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00152	0.00575	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00152	0.00575	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.00148	0.00559	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00142	0.00536	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00139	0.00526	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	0.00136	0.00513	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00129	0.00489	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—FUS—amyotrophic lateral sclerosis	0.00126	0.00477	CbGpPWpGaD
Treprostinil—P2RY12—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00124	0.0047	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	0.00122	0.00462	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00122	0.0046	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—DAO—amyotrophic lateral sclerosis	0.0011	0.00416	CbGpPWpGaD
Treprostinil—PPARD—Gene Expression—RARA—amyotrophic lateral sclerosis	0.00103	0.00389	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.00101	0.0038	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000989	0.00374	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000986	0.00373	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000975	0.00369	CbGpPWpGaD
Treprostinil—PPARD—Wnt Signaling Pathway and Pluripotency—TP53—amyotrophic lateral sclerosis	0.000931	0.00352	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00091	0.00344	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000898	0.00339	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000893	0.00337	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000886	0.00335	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00085	0.00321	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000834	0.00315	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000815	0.00308	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000782	0.00295	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSR—amyotrophic lateral sclerosis	0.00077	0.00291	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000762	0.00288	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000753	0.00285	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000701	0.00265	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000701	0.00265	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000693	0.00262	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00069	0.00261	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000687	0.0026	CbGpPWpGaD
Treprostinil—P2RY12—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000657	0.00248	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000649	0.00245	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000635	0.0024	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000632	0.00239	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000629	0.00238	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000615	0.00232	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000597	0.00226	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000596	0.00225	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000585	0.00221	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000577	0.00218	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000566	0.00214	CbGpPWpGaD
Treprostinil—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000556	0.0021	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00055	0.00208	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000548	0.00207	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000529	0.002	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000523	0.00198	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000518	0.00196	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000487	0.00184	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000482	0.00182	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000477	0.0018	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000437	0.00165	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000426	0.00161	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000403	0.00152	CbGpPWpGaD
Treprostinil—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0004	0.00151	CbGpPWpGaD
Treprostinil—PPARD—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000395	0.00149	CbGpPWpGaD
Treprostinil—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000394	0.00149	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000392	0.00148	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000387	0.00146	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000377	0.00142	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000359	0.00136	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000356	0.00134	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.00034	0.00128	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000338	0.00128	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000337	0.00127	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000331	0.00125	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000321	0.00121	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000312	0.00118	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000312	0.00118	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00031	0.00117	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000306	0.00116	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000306	0.00116	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000296	0.00112	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000285	0.00108	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00028	0.00106	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000275	0.00104	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00026	0.000984	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000258	0.000976	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—APOE—amyotrophic lateral sclerosis	0.000257	0.000971	CbGpPWpGaD
Treprostinil—P2RY12—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000256	0.000966	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000253	0.000956	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000245	0.000925	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000238	0.000899	CbGpPWpGaD
Treprostinil—PTGIR—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000235	0.000889	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000228	0.000863	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.000221	0.000836	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000213	0.000803	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.00021	0.000794	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000196	0.000739	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000176	0.000665	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000176	0.000664	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000168	0.000634	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000162	0.000611	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000155	0.000585	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000141	0.000533	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000135	0.000511	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000128	0.000483	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000127	0.00048	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000124	0.00047	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000118	0.000444	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000116	0.000438	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000115	0.000434	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000106	0.000399	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.67e-05	0.000328	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	7.98e-05	0.000302	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.95e-05	0.0003	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.83e-05	0.000258	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.28e-05	0.000237	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	5.17e-05	0.000195	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.54e-05	0.000134	CbGpPWpGaD
